Effect of carnitine on migraine prophylaxis

Comparison of the effect of carnitine supplementation with sodium valproate in the prophylactic treatment of migraine patients.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190702044073N1

Enrollment

Registered

2019-09-01

Start date

2018-12-22

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine. Migraine

Interventions

Intervention 1: Intervention group: . Intervention 2: Intervention group: .

Eligibility

Sex/Gender

All

Age

15 Years to 60 Years

Inclusion criteria

Inclusion criteria: The number of headache attacks is 4 or more in a month 15 to 60 years old No brain degenerative disease. No Pregnancy and lactation they are not alcoholic or drug user They did not have psychiatric disease or chronic liver or kidney disorders No chronic consumption of pain killer They did not use psychedelic drug

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Headache severity. Timepoint: At the beginning of the study and one month after taking L-Carnitine. Method of measurement: Visual Analogue Scale.	—

Secondary

Measure	Time frame
Duration of headache attack. Timepoint: At the beginning of the study and one month after taking L-Carnitine. Method of measurement: hour.;Frequency of headache repetition. Timepoint: At the beginning of the study and one month after taking L-Carnitine. Method of measurement: Frequency of headache repetition in one month.;Age. Timepoint: At the beginning of the study. Method of measurement: year old.;Sex. Timepoint: At the beginning of the study. Method of measurement: male , female.	—

Measure

Time frame

Duration of headache attack. Timepoint: At the beginning of the study and one month after taking L-Carnitine. Method of measurement: hour.;Frequency of headache repetition. Timepoint: At the beginning of the study and one month after taking L-Carnitine. Method of measurement: Frequency of headache repetition in one month.;Age. Timepoint: At the beginning of the study. Method of measurement: year old.;Sex. Timepoint: At the beginning of the study. Method of measurement: male , female.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazli Barati

Birjand University of Medical Sciences

Nazli.barati@bums.ac.ir+98 56 3239 5000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026